Could a testosterone gel reignite desire in menopausal women?

NCT ID NCT07408440

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a daily testosterone gel to see if it can safely improve sexual interest and arousal in women going through menopause. Researchers will compare the gel to a placebo in 150 women aged 40-65 who have been diagnosed with low sexual desire. The goal is to provide a much-needed treatment option for this common and distressing condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
testosterone gel
What this could lead to
If it works, this could offer a new, FDA-approved treatment option for low sexual desire in menopausal women.
What could go wrong
This trial has not started yet and is relatively small (150 women). The gel may cause side effects like acne or voice changes, and it may not work better than placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIBIDO DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Texas

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.